1-2 of 2
Marco Sorio, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Male Gender, Quality of Grafted Cells, Advanced Age, Rituximab and Radiotherapy Are the Main Factors That Variously Influence the Occurrence of Secondary Malignancies Following High-Dose Therapy and Autograft: A GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) Survey in 1,347 Lymphoma Patients.

Corrado Tarella, MD, Roberto Passera, PhD, Michele Magni, MD, Andrea Rossi, MD, Fabio Benedetti, MD, Angela Gueli, Jr., MD, Caterina Patti, MD, Guido Parvis, MD, Fabio Ciceri, MD, Andrea Gallamini, MD, Sergio Cortelazzo, MD, Paolo Corradini, MD, Valerio Zoli, MD, Antonio Mule', MD, Roberto Crocchiolo, MD, Marco Bosa, MD, Anna Barbui, MD, Massimo Di Nicola, MD, Daniele Caracciolo, MD, Marco Sorio, MD, Alessandro M. Gianni, MD, Alessandro Rambaldi, MD
Journal: Blood
Blood (2009) 114 (22): 519.
https://doi.org/10.1182/blood.V114.22.519.519
Published: 2009
Journal Articles

Favorable Influence of Rituximab with High Dose Sequential Chemotherapy (R-HDS) Programs and Autologous Stem Cell Transplantation (ASCT) in Salvage Treatment for Patients with Refractory or Relapsed B-Cell Non-Hodgkin’s Lymphoma.

Milena Pintimalli, MD, Michael Mian, MD, Andrea Rossi, MD, Marco Sorio, MD, Fabio Benedetti, MD, Giovanni Pizzolo, MD, Atto Billio, MD, Tiziano Barbui, MD, Alessandro Rambaldi, MD, Sergio Cortelazzo, MD
Journal: Blood
Blood (2006) 108 (11): 2744.
https://doi.org/10.1182/blood.V108.11.2744.2744
Published: 2006